FLXN Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (1 jan 1970 @ 01:00):

Flexion Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for the treatment of patients with musculoskeletal conditions...

Stats
Dagens volum	0.00
Gjennomsnittsvolum	2.17M
Markedsverdi	0.00
EPS	$-0.600 ( 2021-11-12 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	0
ATR14	$0.321 (3.52%)

Insider Trading

Date	Person	Action	Amount	type
2021-11-19	Newtyn Management, Llc	Sell	5 900 000	Common Stock, par value $0.001 per share
2021-11-18	Newtyn Management, Llc	Buy	0	Common Stock, par value $0.001 per share
2021-11-19	Stejbach Mark	Sell	12 631	Common Stock
2021-11-19	Stejbach Mark	Sell	25 000	Stock option (right to buy)
2021-11-19	Stejbach Mark	Sell	12 500	Stock option (right to buy)

INSIDER POWER
0.00
Last 99 transactions
Buy: 271 750 \| Sell: 9 779 666

Volum Korrelasjon

Lang: 0.20 (neutral)

Kort: -0.90 (strong negative)

Signal:(61.022) Neutral

Flexion Therapeutics Inc Korrelasjon

10 Mest positive korrelasjoner
ZGNX	0.952
PLPC	0.948
RETA	0.945
RXDX	0.944
OSPN	0.943
FLMN	0.943
FSLR	0.937
ZYNE	0.935
NTAP	0.929
RDNT	0.929

10 Mest negative korrelasjoner
EYE	-0.947
JAKK	-0.939
LMPX	-0.935
CDAK	-0.93
HRZN	-0.928
TTEC	-0.922
DMTK	-0.917
LPSN	-0.917
GBNH	-0.917
TWKS	-0.914

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Flexion Therapeutics Inc Korrelasjon - Valuta/Råvare

0.53
( weak )

-0.19
( neutral )

0.37
( neutral )

0.44
( neutral )

-0.53
( weak negative )

Flexion Therapeutics Inc Økonomi

Annual	2020
Omsetning:	$85.55M
Bruttogevinst:	$66.30M (77.50 %)
EPS:	$-2.53

FY	2020
Omsetning:	$85.55M
Bruttogevinst:	$66.30M (77.50 %)
EPS:	$-2.53

FY	2019
Omsetning:	$72.96M
Bruttogevinst:	$63.00M (86.35 %)
EPS:	$-3.93

FY	2018
Omsetning:	$22.52M
Bruttogevinst:	$15.19M (67.43 %)
EPS:	$-4.49

Financial Reports:

No articles found.

Flexion Therapeutics Inc

Flexion Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for the treatment of patients with musculoskeletal conditions. It offers ZILRETTA, an intra-articular injection for the management of osteoarthritis (OA) pain of the knee in the United States. The company also develops FX201, a gene therapy product candidate designed to stimulate the production of an anti-inflammatory protein, interleukin-1 receptor antagonist for pain relief from OA of the knee; and FX301, an administered NaV1.7 inhibitor for the management of post-operative pain. Flexion Therapeutics, Inc. was founded in 2007 and is headquartered in Burlington, Massachusetts.